To fully implement the spirit of documents such as the Law of the People's Republic of China on Promoting the Transformation of Scientific and Technological Achievements and the Law of the People's Republic of China on Progress in Science and Technology, help various entities further understand and master the relevant policies, models, and processes for the transformation of medical scientific and technological achievements, enhance the research and innovation capabilities of relevant personnel, and improve the efficiency of transforming medical scientific and technological achievements, the Zhongbu Zhiguang Platform is specially organizing the Seminar on the Transformation of Medical Scientific and Technological Achievements and Intellectual Property Management and Operation (Haikou). The relevant matters are hereby notified as follows:
Download Conference Notice
(Scan the QR code to download)
I. Organizing Unit
National Intellectual Property Operation Public Service Platform – University Operation (Wuhan) Pilot Platform
Zhongbu Zhiguang Technology Transfer Co., Ltd.
Hainan Zhiguang Intellectual Property Operation Co., Ltd.
Haikou National High-Tech Industrial Development Zone International Investment Consulting Co., Ltd.
Haikou National High-Tech Industrial Development Zone Incubator Operation and Management Co., Ltd.
Haikou Medicine Valley Biopharmaceutical Innovation Complex
World Intellectual Property Organization Technology and Innovation Support Center
National Public Service Platform for Industrial Technology Foundation, Ministry of Industry and Information Technology
National Overseas Talent Offshore Innovation and Entrepreneurship Base (Wuhan)
VCBeat
II. Time and Venue
April 26–29, 2023 (Registration all day on April 26)
Haikou City, Hainan Province (see subsequent notice for specific address)
III. Attendees
1. Personnel involved in the management of achievement transformation and related staff at medical and health institutions, higher education institutions with biomedical programs, and research institutes；
2. A broad range of holders of medical achievements (clinicians, academic staff at higher education institutions, researchers, etc.);
3. Management and technical personnel in the technology transfer departments of various high-tech industrial parks;
4. Relevant personnel from science and technology administrative departments and public institutions;
5. Science and technology and R&D personnel in various enterprises and public institutions;
6. Relevant personnel interested in the translation of medical achievements, etc.
IV. Conference Agenda
April 26
All Day IHotel Check-in
April 27
08:30-08:40 I Opening Ceremony
Leader's Welcome Address
08:40-10:10 I Policies, Processes, and Practices for the Translation of Medical Scientific and Technological Achievements
Ji JingDirector, Office of Technology Transfer and Commercialization, Shanghai Jiao Tong University School of Medicine
10:20-11:50 I Issues and Countermeasures in the Management of Technological Achievement Transformation
Huang XiaozhenDirector, Department of Science and Technology, Zhongshan Ophthalmic Center, Sun Yat-sen University
11:50-12:00 I Interactive Exchange
14:00-15:30 IExploration of Models for the Translation of Medical Scientific and Technological Achievements
Yu XinyingDeputy Director of the Research Department, Beijing Cancer Hospital (Peking University Cancer Hospital)
15:40-17:10 IPractice and Reflections on the Construction of Medical Science and Technology Innovation Platforms
Li ZhonghuaDirector of the Technology Transfer Department, Guangzhou Regenerative Medicine and Health Guangdong Laboratory
17:10-17:20 I Interactive Session
April 28
08:40-10:10 I Medical Intellectual Property Protection and Management
Huang LuDirector of the Pharmaceutical Professional Committee, China Enterprise Intellectual Property Research Institute; Expert in the National Intellectual Property Expert Pool
10:20-11:50 I Medical Innovation Discovery and Achievement Transformation
Wu DongProfessor at Peking Union Medical College Hospital, Director of the National Health Commission’s Youth Innovation Center
11:50-12:00 I Interactive Exchange
14:00-15:30 I Practices and Experience Sharing in the Transformation of Scientific and Technological Achievements at Qilu Hospital of Shandong University
Yang XiaoyunDirector of the Scientific Research Department, Qilu Hospital of Shandong University
15:30-15:40 I Interactive Communication
15:40-17:10 I Roundtable Discussion
Discussions will focus on the key challenges and priorities in the translation of medical scientific and technological achievements and the management and operation of intellectual property rights, models for translating such achievements and operating intellectual property, and intellectual property management in scientific research projects.
Fang LiDirector of the Xiangya Medical Division, Intellectual Property Center, Central South University (Moderator)
Zhang LiFormer Director of the Medical Science Office, Academy for Advanced Interdisciplinary Studies, Huazhong University of Science and Technology; Former Deputy Dean, Wuhan Economic & Technological Development Zone Institute of Future Technology Innovation
Yuan XiuhongDirector of the Graduate Department, The Third Xiangya Hospital of Central South University; Former Vice President, Haikou People's Hospital
Wang ZhentingHead of the Research Department, Haikou People's Hospital
Chi WenshuoGeneral Manager, Suzhou Medical Device Innovation Center Co., Ltd.
April 29
09:00-11:30 Site Visit and Research Session
V. Conference Expenses
1. The registration fee for this symposium is RMB 3,500 per person; for teams of three or more participants, the fee is RMB 3,200 per person (covering expert lecture fees, materials, venue rental, meals, and conference organization costs).
2. Lunch will be provided free of charge during the conference. Accommodation will be uniformly booked by the conference organizing committee, with costs borne by attendees.。
3. Participants are responsible for their own round-trip transportation costs. The conference organizing committee will not provide station pick-up or drop-off services; please make your own way to the venue.
VI. Registration and Important Notes
Please use WeChat to scan the QR code below and submit your registration information.
Note: Registration will close at 17:00 on April 25, 2023. Please submit your registration information as early as possible to facilitate the conference organizing committee in sending specific check-in notifications.
（1）Bank Transfer: Please remit the conference fee to the following account by 17:00 on April 25 (Note: Specify “Name + Name of Invoice Issuing Entity”).
Account Name: Central China Zhiguang Technology Transfer Co., Ltd.
Tax ID: 91420100347276313K
Account No.: 127908789110802
Bank: China Merchants Bank, Wuhan Branch, Donghu Sub-branch
(2) On-site Payment: Complete the aforementioned online registration process and submit the required information. Payment can be made by card or cash on-site during check-in (please contact Gao Xiaotang in advance at 18571831392, also available via WeChat).
(3) Online Payment: For WeChat online payment, please contact Gao Xiaotang at 18571831392 (WeChat ID is the same).
After successful registration, please scan the QR code below via WeChat to follow the “University IP Operations Platform” service account, select the “Training Activities” section, and click “Submit Invoice Information” to complete the form. Please submit your conference-related information as early as possible to facilitate unified accommodation arrangements and invoice issuance by the conference organizing committee.
VII. Contact Information
Gao Xiaotang: 185 7183 1392
Teacher Dai: 159 7219 3556
VIII. Expert Profiles
PROFILE
Ji Jing
Director, Office of Technology Transfer and Commercialization, Shanghai Jiao Tong University School of Medicine
Chief Physician, Director of the Office of Achievement Transformation at Shanghai Jiao Tong University School of Medicine, overseeing the transfer and commercialization of scientific and technological achievements as well as university-enterprise collaboration. Committee Member of the Youth Committee of the Research Management Branch of the Chinese Medical Association; Deputy Chairman of the Youth Committee of the Research Management Branch of the Shanghai Medical Association. Recipient of multiple honors, including “Advanced Individual in Scientific and Technological Management for the Shanghai Medical Science and Technology Award” and “Advanced Individual in Science and Technology Awards and Achievement Management in Shanghai.”
PROFILE
Huang Xiaozhen
Director, Office of Science and Technology, Zhongshan Ophthalmic Center, Sun Yat-sen University
With 30 years of experience in medical science and technology management (covering scientific projects, achievements, intellectual property, and technology transfer), I previously worked at the Office of Medical Sciences of Sun Yat-sen University. Since 2012, I have served as Director of the Science and Technology Department and Associate Research Fellow at the Zhongshan Ophthalmic Center, Sun Yat-sen University. Over the past decade, I have been deeply engaged in discipline development and science and technology management at the Zhongshan Ophthalmic Center, achieving several successful cases in technology transfer and accumulating substantial management expertise.
PROFILE
Yu Xinying
Deputy Director, Department of Scientific Research, Beijing Cancer Hospital (Peking University Cancer Hospital)
With nearly two decades of experience in scientific research management, I am currently primarily responsible for intellectual property management, transformation of scientific and technological achievements, and industry-university-research collaboration at the hospital. Over the past seven years, I have overseen the signing of technology transfer contracts with a total value of RMB 150 million. I currently serve as a member of the Translational Medicine Professional Committee of the China Medical Education Association, an executive committee member of the Medical Data Analysis Branch of the Beijing Medical Device Industry Association, and a certified technology broker in Beijing. In 2021, I was honored with the Peking University Advanced Individual Award for Industry-University-Research Management.
PROFILE
Li Zhonghua
Director of the Technology Transfer Department, Guangdong Provincial Laboratory of Regenerative Medicine and Health
Possesses extensive experience in technology commercialization, investment and financing, mergers and acquisitions, and international technology licensing. A graduate of the Health Science Center of Peking University, he engaged in nearly a decade of research at The Chinese University of Hong Kong, Radboud University Nijmegen in the Netherlands, the University of Tennessee, and the Cleveland VA Medical Center in the United States, receiving multiple awards from organizations including the International Brain Research Organization. After obtaining an MBA from Case Western Reserve University in the United States in 2006, he dedicated himself to technology commercialization and investment and financing activities. He led Chinese patent auction initiatives that generated significant international impact and completed a series of domestic and international technology transaction projects. He successfully spearheaded the development of China’s first collective fund trust plan based on intellectual property (IP) pledges, actively exploring IP securitization. Furthermore, he initiated and managed the Zhongguancun International Technology Introduction Investment Fund and the ZJ Fukun Venture Capital Fund, with a total scale of RMB 300 million, successfully investing in a portfolio of technology enterprises including Ciming Health Checkup.
Served as the lead consultant for the equity incentive reform pilot program in Zhongguancun, creatively proposing a public disclosure system for the valuation results of state-owned scientific and technological achievements, which became the standardized procedure for Beijing’s equity incentive pilot initiatives. Led the national public trading initiatives for major scientific and technological achievements under the Ministry of Science and Technology, as well as the pilot program for the public trading of military-to-civilian technology transfer under the Ministry of Industry and Information Technology. Based on these efforts, conducted research on mechanisms for the management of state-owned intangible assets. Research and practical experience in the trading of state-owned scientific and technological achievements directly contributed to the enactment of Article 18 of the newly revised Law on Promoting the Transformation of Scientific and Technological Achievements.
Currently serving as the Director of the Technology Transfer Department at Guangzhou International Bio Island Laboratory, he previously held the positions of Deputy Director of the Intellectual Property Trading Center at Beijing Equity Exchange, Vice President of China Technology Exchange, and Deputy General Manager of CAS Innovation Investment Co., Ltd.
Recipient of the Golden Bridge Award for Outstanding Individual; named one of the “Top 10 Influential Figures in Intellectual Property in 2015” by the Beijing Intellectual Property Protection Association; and selected for the “IAM Strategy 300: The World’s Leading IP Strategists 2016” by IAM, the world’s most authoritative magazine on intellectual property management.
PROFILE
Huang Lu
Director of the Pharmaceutical Professional Committee, China Enterprise Intellectual Property Research Institute
Expert, National Intellectual Property Expert Database
Senior Engineer; Expert in the National Intellectual Property Expert Database; One of the Top 100 High-Level Talents in the National "Ten, Hundred, and Thousand" Intellectual Property Talent Project; National Patent Information Instructor; Expert in the Patent Analysis and Early Warning Expert Database of the China National Intellectual Property Administration (CNIPA); Expert in the Science and Technology Consultation Expert Database of the Guangdong Provincial Department of Science and Technology; Expert in the Expert Database for Transformation of Scientific and Technological Achievements in Guangdong Universities; Talent under the Wuhan "Yellow Crane Elite (Science and Technology) Plan"; External Master’s Supervisor for the Master of Pharmacy program at Wuhan University; Part-time Master’s Supervisor for the Juris Master (Law) professional degree program at Wuhan University of Technology; External Master’s Supervisor for the professional master’s degree program at the School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology; External Master’s Supervisor for the Juris Master professional degree program at the School of Law and Business, Wuhan Institute of Technology.With 19 years of extensive practical experience, specializing in the development and project management of innovative drugs, generic drugs, and Class III medical devices; intellectual property management in pharmaceutical enterprises; and product initiation and competitive intelligence work. Recipient of the Third Prize of the Wuhan Science and Technology Progress Award (2012); Bronze Award in the Enterprise Category of the 2018 Guangdong "Zhongchuang Cup" Doctoral and Postdoctoral Entrepreneurship and Innovation Competition; Silver Award in the 2019 Hubei Province High-Value Patent Competition; and Excellence Award in the Biopharmaceutical Industry Track of the Guangdong Division of the 8th China Innovation and Entrepreneurship Competition. Co-editor-in-chief of two books: *New Technologies in Pharmaceutical Formulations and Product Development* and *Intellectual Property Management in Chinese Pharmaceutical Enterprises*. As an inventor by virtue of employment, granted over 100 domestic and foreign invention patents. Published more than 30 academic papers in pharmaceutical journals such as *Chinese Journal of New Drugs*, including one paper selected for the 2017 F5000 (Top 50 Most Influential International Academic Papers by Chinese Scholars) and three papers selected as CNKI High-Impact Papers (2011–2022).
PROFILE
Wu Dong
Professor, Peking Union Medical College Hospital
National Health CommissionDirector, Center for Youth Innovation
Chief Physician, Department of Gastroenterology; Professor; Doctoral Supervisor; Deputy Director, Department of Internal Medicine, Peking Union Medical College Hospital; Director, National Health Commission Youth Innovation Center; National Young Post Expert in the Health System; Beijing Municipal Young Teaching Master at Universities and Colleges; Advisor, China Food and Drug Enterprise Quality and Safety Promotion Association.
Chinese Medical Association: Member of the Clinical Evidence-Based Medicine Group, Branch of Internal Medicine; Member of the Pancreatology Group, Branch of Gastroenterology; Member of the Collaborative Group on Difficult and Critical Diseases and Clinical Thinking; Member of the Colonoscopy Group, Branch of Digestive Endoscopy.
Authored 32 SCI-indexed papers as first or corresponding author, with a cumulative impact factor of 215.46; holds 40 granted invention and utility model patents; recipient of the First Prize for Medical Research Innovation from the Chinese Research Hospital Association; serves on the editorial boards of Chinese Journal of Clinical Nutrition and Chinese Journal of General Practitioners, and as a corresponding editorial board member for Chinese Journal of Digestion and Chinese Journal of Digestive Endoscopy.
PROFILE
Yang Xiaoyun
Director of the Scientific Research Department, Qilu Hospital of Shandong University
Chief Physician, Department of Gastroenterology, Qilu Hospital of Shandong University; Young Committee Member, Branch of Medical Research Management, Chinese Medical Association; Young Committee Member, Branch of Clinical Epidemiology and Evidence-Based Medicine, Chinese Medical Association; Young Committee Member, Branch of Parenteral and Enteral Nutrition, Chinese Medical Association; Vice Chairman, Branch of Medical Research Management, Shandong Medical Association; Committee Member, Branch of Clinical Epidemiology and Evidence-Based Medicine, Shandong Medical Association; Standing Committee Member, Branch of Research Ethics, Shandong Society for Medical Ethics; Deputy Leader, Pancreatology Group, Branch of Gastroenterology, Shandong Medical Association; Young Committee Member, Branch of Gastroenterology, Cross-Strait Medical and Health Exchange Association.
PROFILE
Fang Li
Director of the Xiangya Medical Department, Intellectual Property Center, Central South University
Associate Researcher, Ph.D. Candidate in International Intellectual Property Law, Master of Medicine; Director of the Office for Discipline Construction and Planning at the Third Xiangya Hospital of Central South University; Deputy Director of the Intellectual Property Center of Central South University and Director of its Xiangya Medical Division; Head of the Technology Transfer Department at the National Engineering Research Center for Individualized Diagnosis and Treatment and Furong Laboratory. Formerly served as Deputy Director of the Research Department at Xiangya Hospital of Central South University and Assistant at the Yale-China Association, Yale University. Major social appointments include Expert in the Strategic Research Group on Health and Healthcare Technology Transfer under the Ministry of Science and Technology, Project Review Expert for the Chinese Red Cross Foundation, and Executive Director of the Hunan Province Intellectual Property Law Research Society. With over ten years of experience in scientific research management and technology transfer, has led and participated in numerous research projects funded by the WHO, CMB, national, provincial, and ministerial authorities. Has published multiple papers on research management and technology transfer, with think tank articles published in the “Hunan Provincial Think Tank Special Report” receiving important instructions from provincial leaders.
Zhongbu Zhiguang Technology Transfer Co., Ltd. serves as the entity responsible for constructing and operating five national-level platforms: the University Operations Pilot Platform of the National Intellectual Property Operation Public Service Platform (Wuhan), the Comprehensive Service Market for Technology Transfer under the National Central China Technology Transfer Center, the National Overseas Talent Offshore Innovation and Entrepreneurship Base (Wuhan), the Industrial Technology Foundation Public Service Platform of the Ministry of Industry and Information Technology, and the World Intellectual Property Organization (WIPO) Technology and Innovation Support Center. The company participated in the establishment of the University Governance Research Center at China University of Geosciences (Wuhan) under the Ministry of Education. Focusing on university intellectual property (IP) operations and the commercialization of scientific achievements, the company adopts “strategic layout prior to operation” as its core operational philosophy, places talent at the center, and employs an “IP+” business model. It closely integrates IP with technological innovation, technology transfer, achievement commercialization, innovation and entrepreneurship, industrial incubation, and investment and talent attraction, thereby building a full-value-chain service system for university IP operations and achievement commercialization. By extensively connecting with universities and research institutes, government industrial parks, enterprises and public institutions, alliances and associations, and incubators, the company has established a distinctive service model.
Future Medical Achievement Transformation and Cooperation Conference (VB-Link Conference)YesVCBeat and VB100 launched the first domesticA market-driven industry summit focused on sharing cutting-edge insights, showcasing achievements, and facilitating matchmaking and collaboration in the translation of medical scientific and technological innovations. Inaugural Edition ContentIncluding the collection of innovation needs from leading enterprises, the Future Medical Specialty Innovation Solutions Challenge, the VB-Link Awards series, the White Paper on Clinical Pain Points, and the Young Scientists’ Translational Innovation Summit.Diverse content, expected to attract over200+ Competing Projects, 100+ Keynote Speakers, 800+ AttendeesAttend the conference.
Click the link for conference details: http://vb100.vcbeat.top/vblink orScan QR CodeEnter。
